Cite
HARVARD Citation
Crosby, E. et al. (2020). Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio. Journal for immunotherapy of cancer. 8 (2), p. . [Online].